PDS Biotechnology's total assets for Q3 2025 were $34.71M, a decrease of -14.26% from the previous quarter. PDSB total liabilities were $25.25M for the fiscal quarter, a 3.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.